Evidence map›Paper›PMID 25180231›Full record

ArticleThe EMBO journal2014

Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.

Cecilia Rocha, Laura Papon, Wulfran Cacheux, Patricia Marques Sousa, Valeria Lascano, Olivia Tort, Tiziana Giordano, Sophie Vacher, Benedicte Lemmers, Pascale Mariani and 5 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. An intestinal TNature immunology · 2024
    Article
  13. Article
  14. Tubulin Complexity in Cancer and Metastasis.Advances in experimental medicine and biology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Long Noncoding RNAs in Taxane Resistance of Breast Cancer.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Cecilia RochaInstitut Curie, Orsay, France PSL Research University, Paris, France CNRS UMR3306, Orsay, France INSERM U1005, Orsay, France IGMM CNRS UMR5535, Montpellier, France Université Montpellier Sud de France, Montpellier, France.
Laura PaponIGMM CNRS UMR5535, Montpellier, France Université Montpellier Sud de France, Montpellier, France.
Wulfran CacheuxInstitut Curie Hospital, Paris, France.
Patricia Marques SousaInstitut Curie, Orsay, France PSL Research University, Paris, France CNRS UMR3306, Orsay, France INSERM U1005, Orsay, France.
Valeria LascanoAcademic Medical Center, Amsterdam, The Netherlands.
Olivia TortInstitut Curie, Orsay, France PSL Research University, Paris, France CNRS UMR3306, Orsay, France INSERM U1005, Orsay, France Institut de Biotecnologia i de Biomedicina, Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain.
Tiziana GiordanoInstitut Curie, Orsay, France PSL Research University, Paris, France CNRS UMR3306, Orsay, France INSERM U1005, Orsay, France.
Sophie VacherInstitut Curie Hospital, Paris, France.
Benedicte LemmersIGMM CNRS UMR5535, Montpellier, France Université Montpellier Sud de France, Montpellier, France.
Pascale MarianiInstitut Curie Hospital, Paris, France.
Didier MeseureInstitut Curie Hospital, Paris, France.
Jan Paul MedemaAcademic Medical Center, Amsterdam, The Netherlands.
Ivan BiècheInstitut Curie Hospital, Paris, France.
Michael HahneIGMM CNRS UMR5535, Montpellier, France Université Montpellier Sud de France, Montpellier, France Academic Medical Center, Amsterdam, The Netherlands carsten.janke@curie.fr hahne@igmm.cnrs.fr.
Carsten JankeInstitut Curie, Orsay, France PSL Research University, Paris, France CNRS UMR3306, Orsay, France INSERM U1005, Orsay, France carsten.janke@curie.fr hahne@igmm.cnrs.fr.
Institut Curie · FRCentre National de la Recherche Scientifique · FRAcademic Medical Center · NLUniversité de Montpellier · FRUniversité Paris Sciences et Lettres · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TTLL3 and TTLL8 are tubulin glycine ligases catalyzing posttranslational glycylation of microtubules. We show here for the first time that these enzymes are required for robust formation of primary cilia. We further discover the existence of primary cilia in colon and demonstrate that TTLL3 is the only glycylase in this organ. As a consequence, colon epithelium shows a reduced number of primary cilia accompanied by an increased rate of cell division in TTLL3-knockout mice. Strikingly, higher proliferation is compensated by faster tissue turnover in normal colon. In a mouse model for tumorigenesis, lack of TTLL3 strongly promotes tumor development. We further demonstrate that decreased levels of TTLL3 expression are linked to the development of human colorectal carcinomas. Thus, we have uncovered a novel role for tubulin glycylation in primary cilia maintenance, which controls cell proliferation of colon epithelial cells and plays an essential role in colon cancer development.

Indexed as

Cell ProliferationAnimalsBlotting, WesternCarcinogensCells, CulturedCiliaColonColonic NeoplasmsColorectal NeoplasmsDisease Models, AnimalEmbryo, MammalianEpithelial CellsFibroblastsGlycineHumansImmunoenzyme TechniquesCarcinogensGlycinePeptide SynthasesRNA, MessengerTubulincolorectal cancermicrotubule glycylationprimary ciliaproliferationtubulin posttranslational modification

Identifiers

PMID25180231
PMCPMC4282510
OpenAlexW2120282773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.